METROPOLITAN LIFE INSURANCE CO/NY - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 70 filers reported holding OVID THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,622
+17.1%
3,2870.0%0.00%0.0%
Q2 2023$10,781
-74.1%
3,287
-54.6%
0.00%0.0%
Q3 2020$41,604
-61.0%
7,248
-49.9%
0.00%
-50.0%
Q2 2020$106,57014,4600.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,252,892$10,930,0004.97%
GLOBEFLEX CAPITAL L P 1,397,770$4,697,0001.02%
BVF INC/IL 6,631,051$22,280,0000.87%
EcoR1 Capital, LLC 6,082,200$20,436,0000.71%
Ikarian Capital, LLC 1,105,082$3,715,0000.26%
CHI Advisors LLC 233,510$785,0000.23%
DCF Advisers, LLC 141,701$476,0000.21%
Artal Group S.A. 2,500,000$8,400,0000.19%
PLATINUM INVESTMENT MANAGEMENT LTD 766,901$2,577,0000.07%
ACADIAN ASSET MANAGEMENT LLC 1,903,162$6,394,0000.02%
View complete list of OVID THERAPEUTICS INC shareholders